SMT202000653T1 - Nuovi inibitori di callicreina 7 - Google Patents
Nuovi inibitori di callicreina 7Info
- Publication number
- SMT202000653T1 SMT202000653T1 SM20200653T SMT202000653T SMT202000653T1 SM T202000653 T1 SMT202000653 T1 SM T202000653T1 SM 20200653 T SM20200653 T SM 20200653T SM T202000653 T SMT202000653 T SM T202000653T SM T202000653 T1 SMT202000653 T1 SM T202000653T1
- Authority
- SM
- San Marino
- Prior art keywords
- inhibitors
- kallikrein
- new
- new kallikrein
- Prior art date
Links
- 102100034867 Kallikrein-7 Human genes 0.000 title 1
- 101710176222 Kallikrein-7 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1430004 | 2014-01-23 | ||
| EP15740983.0A EP3097084B1 (en) | 2014-01-23 | 2015-01-22 | New kallikrein 7 inhibitors |
| PCT/SE2015/050060 WO2015112079A1 (en) | 2014-01-23 | 2015-01-22 | New kallikrein 7 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT202000653T1 true SMT202000653T1 (it) | 2021-01-05 |
Family
ID=53681745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20200653T SMT202000653T1 (it) | 2014-01-23 | 2015-01-22 | Nuovi inibitori di callicreina 7 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9744148B2 (enExample) |
| EP (1) | EP3097084B1 (enExample) |
| JP (2) | JP6552010B2 (enExample) |
| CN (1) | CN106132940B (enExample) |
| AU (1) | AU2015209759B2 (enExample) |
| CA (1) | CA2934024C (enExample) |
| CY (1) | CY1123707T1 (enExample) |
| DK (1) | DK3097084T3 (enExample) |
| ES (1) | ES2834851T3 (enExample) |
| HR (1) | HRP20201915T1 (enExample) |
| HU (1) | HUE052990T2 (enExample) |
| LT (1) | LT3097084T (enExample) |
| PL (1) | PL3097084T3 (enExample) |
| PT (1) | PT3097084T (enExample) |
| RS (1) | RS61142B1 (enExample) |
| SI (1) | SI3097084T1 (enExample) |
| SM (1) | SMT202000653T1 (enExample) |
| WO (1) | WO2015112079A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9744148B2 (en) * | 2014-01-23 | 2017-08-29 | Sixera Pharma Ab | Kallikrein 7 inhibitors |
| EP3305781A1 (en) * | 2016-10-07 | 2018-04-11 | Deutsches Krebsforschungszentrum | Chemical substances which inhibit the enzymatic activity of human kallikrein-related peptidase 6 (klk6) |
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AR119997A1 (es) | 2019-09-18 | 2022-01-26 | Genentech Inc | Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso |
| CN117084936A (zh) * | 2023-09-22 | 2023-11-21 | 南京盛德生物科技研究院有限公司 | 多萜类化合物作为激肽释放酶抑制剂在化妆品中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2514355A1 (fr) * | 1981-10-14 | 1983-04-15 | Fabre Sa Pierre | Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments |
| WO2003101941A2 (en) | 2002-05-31 | 2003-12-11 | Genzyme Corporation | Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| DK1631295T3 (da) | 2003-06-06 | 2010-06-21 | Arexis Ab | Anvendelse af kondenserede heterocykliske forbindelser som SCCE-inhibitorer ved behandling af hudsygdomme |
| US8486863B2 (en) * | 2006-11-23 | 2013-07-16 | Vib Vzw | Activators of lateral root formation |
| JP2010532162A (ja) | 2007-06-28 | 2010-10-07 | ノバルティス アーゲー | カリクレイン７モジュレーター |
| ES2527298T3 (es) * | 2007-08-17 | 2015-01-22 | Novartis Ag | Uso de depsipéptidos cíclicos para inhibir calicreína 7 |
| CN103298827B (zh) | 2007-08-17 | 2017-05-31 | 诺华股份有限公司 | 环状酯肽 |
| US8143269B2 (en) | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| EP2545916A1 (en) | 2011-07-15 | 2013-01-16 | Universite Pierre Et Marie Curie - Paris 6 | Use of coumarin derivatives for the preparation of drugs for treating skin diseases |
| US9744148B2 (en) * | 2014-01-23 | 2017-08-29 | Sixera Pharma Ab | Kallikrein 7 inhibitors |
-
2015
- 2015-01-22 US US15/113,658 patent/US9744148B2/en active Active
- 2015-01-22 CA CA2934024A patent/CA2934024C/en active Active
- 2015-01-22 EP EP15740983.0A patent/EP3097084B1/en active Active
- 2015-01-22 SM SM20200653T patent/SMT202000653T1/it unknown
- 2015-01-22 LT LTEP15740983.0T patent/LT3097084T/lt unknown
- 2015-01-22 ES ES15740983T patent/ES2834851T3/es active Active
- 2015-01-22 CN CN201580005402.3A patent/CN106132940B/zh active Active
- 2015-01-22 RS RS20201461A patent/RS61142B1/sr unknown
- 2015-01-22 WO PCT/SE2015/050060 patent/WO2015112079A1/en not_active Ceased
- 2015-01-22 JP JP2016544671A patent/JP6552010B2/ja active Active
- 2015-01-22 PL PL15740983.0T patent/PL3097084T3/pl unknown
- 2015-01-22 HR HRP20201915TT patent/HRP20201915T1/hr unknown
- 2015-01-22 AU AU2015209759A patent/AU2015209759B2/en not_active Ceased
- 2015-01-22 DK DK15740983.0T patent/DK3097084T3/da active
- 2015-01-22 SI SI201531440T patent/SI3097084T1/sl unknown
- 2015-01-22 PT PT157409830T patent/PT3097084T/pt unknown
- 2015-01-22 HU HUE15740983A patent/HUE052990T2/hu unknown
-
2019
- 2019-05-14 JP JP2019091722A patent/JP6932386B2/ja active Active
-
2020
- 2020-12-04 CY CY20201101150T patent/CY1123707T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6552010B2 (ja) | 2019-07-31 |
| CA2934024A1 (en) | 2015-07-30 |
| CN106132940A (zh) | 2016-11-16 |
| US20170000753A1 (en) | 2017-01-05 |
| LT3097084T (lt) | 2020-12-28 |
| EP3097084A1 (en) | 2016-11-30 |
| HUE052990T2 (hu) | 2021-05-28 |
| JP6932386B2 (ja) | 2021-09-08 |
| SI3097084T1 (sl) | 2021-01-29 |
| RS61142B1 (sr) | 2020-12-31 |
| EP3097084A4 (en) | 2017-10-04 |
| CA2934024C (en) | 2022-08-23 |
| EP3097084B1 (en) | 2020-09-30 |
| JP2019163296A (ja) | 2019-09-26 |
| AU2015209759B2 (en) | 2018-11-29 |
| ES2834851T3 (es) | 2021-06-18 |
| CY1123707T1 (el) | 2022-03-24 |
| CN106132940B (zh) | 2019-04-23 |
| WO2015112079A1 (en) | 2015-07-30 |
| PL3097084T3 (pl) | 2021-02-22 |
| AU2015209759A1 (en) | 2016-07-07 |
| HRP20201915T1 (hr) | 2021-01-22 |
| DK3097084T3 (da) | 2020-12-21 |
| US9744148B2 (en) | 2017-08-29 |
| PT3097084T (pt) | 2020-12-09 |
| JP2017505299A (ja) | 2017-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287113A (en) | smyd inhibitors | |
| IL280785A (en) | Human plasma kallikrein inhibitors | |
| IL259560A (en) | Inhibitors of the menin-mll interaction | |
| IL250642A0 (en) | glycosidase inhibitors | |
| ZA201608847B (en) | Beta-lactamase inhibitors | |
| IL246362A0 (en) | Novel glutaminase inhibitors | |
| IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
| GB201421088D0 (en) | New enzyme inhibitors | |
| IL248895A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| GB201416446D0 (en) | New enzyme inhibitor compounds | |
| GB201421085D0 (en) | New enzyme inhibitors | |
| GB201403536D0 (en) | Inhibitor compounds | |
| IL265139B (en) | Dopamine-b-hydroxylase inhibitors | |
| PT3227325T (pt) | Composições inibidoras seletivas da sinalização trans de il-6 | |
| GB201612860D0 (en) | Inhibitors | |
| GB201501004D0 (en) | Inhibitors | |
| LT3097084T (lt) | Nauji kalikreino 7 inhibitoriai | |
| GB201520949D0 (en) | Inhibitors | |
| DK3237407T3 (da) | 3,5-diaminopyrazolkinasehæmmere | |
| GB201401005D0 (en) | Inhibitor | |
| GB201418154D0 (en) | Inhibitors | |
| IL233408A0 (en) | New Skin - Perineal | |
| GB201413310D0 (en) | Taggstar 2 | |
| GB201413313D0 (en) | Kapiche 1 |